EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy

Thomas F Stoop, Atsushi Oba, Y H Andrew Wu, Laurel E Beaty, Kathryn L Colborn, Boris V Janssen, Mohammed H Al-Musawi, Salvador Rodriguez Franco, Toshitaka Sugawara, Oskar Franklin, Ajay Jain, Akio Saiura und 48 weitere

JAMA Network Open · 18.06.2024 · 7 (6) · e2417625

DOI: 10.1001/jamanetworkopen.2024.17625 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Network Open, online erschienen am 18.06.2024. Verfasst von Thomas F Stoop und 59 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, University of Colorado, Anschutz Medical Campus, Aurora. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Preoperative chemo(radio)therapy is increasingly used in patients with localized pancreatic adenocarcinoma, leading to pathological complete response (pCR) in a small subset of patients. However, multicenter studies with in-depth data about pCR are lacking.

Objective

To investigate the incidence, outcome, and risk factors of pCR after preoperative chemo(radio)therapy. Design, Setting, and Participants This observational, international, multicenter cohort study assessed all consecutive patients with pathology-proven localized pancreatic adenocarcinoma who underwent resection after 2 or more cycles of chemotherapy (with or without radiotherapy) in 19 centers from 8 countries (January 1, 2010, to December 31, 2018). Data collection was performed from February 1, 2020, to April 30, 2022, and analyses from January 1, 2022, to December 31, 2023. Median follow-up was 19 months. Exposures Preoperative chemotherapy (with or without radiotherapy) followed by resection. Main Outcomes and Measures The incidence of pCR (defined as absence of vital tumor cells in the sampled pancreas specimen after resection), its association with OS from surgery, and factors associated with pCR. Factors associated with overall survival (OS) and pCR were investigated with Cox proportional hazards and logistic regression models, respectively.

Results

Overall, 1758 patients (mean [SD] age, 64 [9] years; 879 [50.0%] male) were studied. The rate of pCR was 4.8% (n = 85), and pCR was associated with OS (hazard ratio, 0.46; 95% CI, 0.26-0.83). The 1-, 3-, and 5-year OS rates were 95%, 82%, and 63% in patients with pCR vs 80%, 46%, and 30% in patients without pCR, respectively ( P < .001). Factors associated with pCR included preoperative multiagent chemotherapy other than (m)FOLFIRINOX ([modified] leucovorin calcium [folinic acid], fluorouracil, irinotecan hydrochloride, and oxaliplatin) (odds ratio [OR], 0.48; 95% CI, 0.26-0.87), preoperative conventional radiotherapy (OR, 2.03; 95% CI, 1.00-4.10), preoperative stereotactic body radiotherapy (OR, 8.91; 95% CI, 4.17-19.05), radiologic response (OR, 13.00; 95% CI, 7.02-24.08), and normal(ized) serum carbohydrate antigen 19-9 after preoperative therapy (OR, 3.76; 95% CI, 1.79-7.89). Conclusions and Relevance This international, retrospective cohort study found that pCR occurred in 4.8% of patients with resected localized pancreatic adenocarcinoma after preoperative chemo(radio)therapy. Although pCR does not reflect cure, it is associated with improved OS, with a doubled 5-year OS of 63% compared with 30% in patients without pCR. Factors associated with pCR related to preoperative chemo(radio)therapy regimens and anatomical and biological disease response features may have implications for treatment strategies that require validation in prospective studies because they may not universally apply to all patients with pancreatic adenocarcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsAdenocarcinomaHumansMaleMiddle AgedFemaleAgedNeoadjuvant TherapyAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeCohort StudiesOxaliplatinPancreatectomy

Substanzen

Oxaliplatin

Autor:innen und Institutionen

  • Division of Surgical Oncology, Department of Surgery, University of Colorado, Anschutz Medical Campus, Aurora.
  • Amsterdam UMC, University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
  • Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Department of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan.
  • Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Division of Hepatobiliary and Pancreatic Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Zitieren

APA

Stoop, T. F., Oba, A., Wu, Y. H. A., Beaty, L. E., Colborn, K. L., Janssen, B. V., Al-Musawi, M. H., Franco, S. R., Sugawara, T., Franklin, O., Jain, A., Saiura, A., Sauvanet, A., Coppola, A., Javed, A. A., Groot Koerkamp, B., Miller, B. N., Mack, C. E., Hashimoto, D., …, & Wilmink, J. W. (2024). Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy. JAMA Network Open, 7(6), e2417625. https://doi.org/10.1001/jamanetworkopen.2024.17625

Vancouver

Stoop TF, Oba A, Wu YHA, Beaty LE, Colborn KL, Janssen BV, et al. Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy. JAMA Network Open. 2024;7(6):e2417625. doi:10.1001/jamanetworkopen.2024.17625

BibTeX
@article{Stoop2024,
  author = {Stoop, Thomas F and Oba, Atsushi and Wu, Y H Andrew and Beaty, Laurel E and Colborn, Kathryn L and Janssen, Boris V and Al-Musawi, Mohammed H and Franco, Salvador Rodriguez and Sugawara, Toshitaka and Franklin, Oskar and Jain, Ajay and Saiura, Akio and Sauvanet, Alain and Coppola, Alessandro and Javed, Ammar A and Groot Koerkamp, Bas and Miller, Braden N and Mack, Claudia E and Hashimoto, Daisuke and Caputo, Damiano and Kleive, Dyre and Sereni, Elisabetta and Belfiori, Giulio and Ichida, Hirofumi and van Dam, Jacob L and Dembinski, Jeanne and Akahoshi, Keiichi and Roberts, Keith J and Tanaka, Kimitaka and Labori, Knut J and Falconi, Massimo and House, Michael G and Sugimoto, Motokazu and Tanabe, Minoru and Gotohda, Naoto and Krohn, Paul S and Burkhart, Richard A and Thakkar, Rohan G and Pande, Rupaly and Dokmak, Safi and Hirano, Satoshi and Burgdorf, Stefan K and Crippa, Stefano and van Roessel, Stijn and Satoi, Sohei and White, Steven A and Hackert, Thilo and Nguyen, Trang K and Yamamoto, Tomohisa and Nakamura, Toru and Bachu, Vismaya and Burns, William R and Inoue, Yosuke and Takahashi, Yu and Ushida, Yuta and Aslami, Zohra V and Verbeke, Caroline S and Fariña, Arantza and He, Jin and Wilmink, Johanna W},
  title = {Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {6},
  pages = {e2417625},
  doi = {10.1001/jamanetworkopen.2024.17625}
}
Kostenlos starten →